Scorr-Insert
X

Overview of Oxaprozin

Client Email Product
Prestwick3_001060
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

0

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

MEDIA

Blog

0

News

REFERENCE STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

ListLIST
  • FDA
  • EDQM
Applications: It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.
Ingredient(s): HPMC AS
Dosage Form: Capsule
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Complies with relevant European, Japanese and US Pharmacopeia monographs
Technical Specifications: Water content – less than 6%; Size #0
  • WHO-GMP
Applications: Pharmacel® 101 is a strong binder for wet & dry granulation formulations as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration properties.
Dosage Form: Tablet
More Info on Category: Fillers, Diluents & Binders
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP, IP
Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57
  • FDA
  • EDQM
Applications: Advantose® FS95 spray-dried fructose is coprocessed with a small quantity of starch, which results in a highly compressible excipient for pharmaceutical, nutraceutical, and chewable vitamin applications.
Ingredient(s): Fructose
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Ready mix Film coating system for moisture sensitive APIs
Ingredient(s): Stearic Acid
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP / EP / JP; Having US-DMF
Technical Specifications: Moisture barrier film coating system
  • WHO-GMP
Applications: Polysorbate 80 in dry powder form
Ingredient(s): Polysorbate 80
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: USP-NF / EP / JP & having US DMF
Technical Specifications: Solubilizer in powder form, used in directly compressible dosage forms, Wet granulation, added during lubrication stage
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
Applications: Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • WHO-GMP
Applications: Pharmacel® 102 has good flow properties enabling high speed direct compression tableting. It is a ideal choice for direct compression & dry granulation formulations and it also has some lubrication properties for smooth tableting experience.
Dosage Form: Tablet
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP, IP
Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90-180 ?m; Hausner ratio-1,42
  • WHO-GMP
Applications: Primellose® croscarmellose sodium is an effective super-disintegrant ,suitable for a variety of tablet and capsule formulations. It is effective when used intragranular and/or extragranular in granular formulations.
Ingredient(s): Croscarmellose Sodium
More Info on Category: Disintegrants & Superdisintegrants
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: DRcaps® are made with an innovative HPMC formulation that can help protect sensitive ingredients from the low pH environment of the stomach. The low-moisture level of DRcaps® provides enhanced stability for hygroscopic ingredients.
Dosage Form: Capsule
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications
Technical Specifications: Size # 0-1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

Advertise With Us

Advertise With Us